‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks

Martin Shkreli, a former hedge-fund manager known as “Pharma Bro,” is back in the crosshairs of U.S. regulators for influencing biopharma stocks even though he is banned from…

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketwatch.com)